Best Professional Development Grants for Nonprofits in Maryland

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Acute Myeloid Leukemia (AML) Fund

Help with healthcare costs for acute myeloid leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The AMA Foundation Award for Health Education recognizes the exemplary educational efforts of physicians, medical students, and residents dedicated to improving public health. Supported by a $3,500 stipend from the John P. McGovern Foundation, this award celebrates individuals who demonstrate outstanding commitment to service, community involvement, and leadership in health education. Eligible candidates include practicing physicians, with special consideration for those addressing issues related to alcohol, tobacco, and other drugs.

The Amyotrophic Lateral Sclerosis Fund, managed by HealthWell Foundation, aims to alleviate financial barriers for underinsured patients battling ALS, a progressive neurodegenerative disease. The fund provides financial assistance for prescription copays, insurance premiums, and related healthcare expenses, ensuring patients can access vital treatments. With an average grant utilization of $3,000 over twelve months, the fund exemplifies HealthWell's commitment to ensuring no patient is denied necessary healthcare due to cost. Since 2004, HealthWell has awarded over $1.2 billion in grants, supporting more than 1.1 million patients.

The Alagille Syndrome Vitamins and Supplements Fund, managed by the HealthWell Foundation, offers financial assistance to patients suffering from Alagille Syndrome. This fund helps cover the costs of essential vitamins and supplements needed for treatment. With a maximum award of $1,500, the program aims to reduce financial barriers for underinsured individuals, ensuring they receive the necessary support to manage their health, thereby enhancing their quality of life.

The M&T Charitable Foundation Grants provide essential support to a variety of organizations focused on enhancing community well-being. With a mission rooted in corporate responsibility, the foundation prioritizes partnerships with 501(c)(3) organizations in sectors such as arts, health, education, and human services. By investing in local initiatives, the foundation aims to create healthier communities and improve the quality of life for all stakeholders involved.

The Rural Health Network Development Program aims to enhance health care access in rural areas by supporting integrated health care networks. It offers two funding tracts: the Network Advancement Tract for established networks to overcome operational barriers and the Network Development Tract for early-stage networks to plan and expand services. Both tracts focus on improving care coordination, health outcomes, and operational efficiency, thereby strengthening the rural health care system.

The OREF/John W. Brown Early-Stage Investigator Grant supports innovative research in musculoskeletal health, encouraging early-stage investigators to submit proposals utilizing enabling technologies. Established by the Orthopaedic Research and Education Foundation, this grant honors John W. Brown's contributions to orthopaedics. With a maximum funding of $100,000 over one or two years, the grant aims to enhance clinical practice and improve patient outcomes through groundbreaking research.

The Rural Health Network Development Planning Program aims to enhance rural health care by fostering integrated health care networks. It focuses on collaboration among entities to bolster local capacity and improve care coordination in underserved areas. By achieving efficiencies and expanding access to essential services, the program seeks to strengthen the overall rural health system while promoting the use of health information technology and exploring innovative care delivery models.

The Mentored Research Scientist Career Development Award (KR1) offers crucial support for researchers aiming for independence. Funded by the US Dept. of Health & Human Services through the NIH, this award allows candidates to engage in intensive research training under a mentor's guidance for up to five years. It is designed for those with research doctoral degrees, facilitating their transition into independent research roles and enhancing their contributions to the scientific community.

The Barbara Hodgdon Award, presented by the Shakespeare Association of America (SAA), honors exceptional scholarship in the field of Shakespeare and Performance. Established in memory of Barbara Hodgdon, this award encourages innovative research across various media and time periods related to Shakespeare's work. Eligible submissions must be authored by SAA members and published two years prior to the award presentation. This recognition promotes new discussions and insights within the realm of Shakespearean performance studies.

The Mentored Clinician Research Scientist Career Development Award (KC1) from the NIH supports clinician research scientists for up to five years, providing dedicated time for intensive research career development. This award aims to guide candidates with clinical doctoral degrees towards achieving research independence by pairing them with experienced mentors who can help navigate their career paths.

The Wexner Davidson Fellowship (WDF) is a transformative leadership development program designed for Jewish communal professionals in North America aged 26-36. Over three years, Fellows engage in cohort-based learning at biannual institutes, receive coaching, and deepen their Jewish knowledge while building a strong professional network. This initiative fosters personal and professional growth, equipping the next generation of leaders to serve their communities effectively and connect with a global alumni network.

The Mentored Career Transition Award (KT1/R00) offers a biphasic funding opportunity for up to 5 years, supporting the transition of postdoctoral researchers to independent faculty positions. The first phase provides 1-2 years of mentored career development, while the second phase grants up to 3 years of independent research support, contingent upon satisfactory progress and faculty appointment. This grant aims to enhance the capacity of early-career researchers in achieving research-intensive roles.

The Established Clinician Investigator Award to Support Mentoring (KS1) is designed to provide established clinician investigators with dedicated time for mentoring early-career clinician research scientists. This initiative by the US Dept. of Health & Human Services: National Institutes of Health (NIH) aims to enhance the quality of mentorship, fostering the development of future leaders in clinical research. It supports a sustained commitment to training and guidance, ensuring a robust pipeline of skilled professionals.

The Wexner Field Fellowship is a three-year program aimed at enhancing the leadership skills of Jewish professionals in North America. Participants engage in leadership institutes, receive personalized coaching, and gain access to professional development funds. This fellowship fosters a robust network of leaders committed to serving the Jewish community, encouraging a deeper understanding of its diversity and strengthening essential leadership competencies. Eligible candidates must be full-time employees at Jewish organizations with at least five years of relevant experience.

The Corporate Giving Program by Cytokinetics focuses on health equity in cardiovascular disease, targeting underserved communities. It seeks to fund initiatives that address disparities in healthcare access, including public health campaigns, community support programs, and innovative solutions. Eligible organizations must be 501(c)(3) nonprofits in the U.S. that align with these goals, ensuring that no direct healthcare practice involvement occurs. This initiative aims to foster equitable health outcomes and enhance community well-being.

The Bauer Trust Fund Grant supports charitable organizations benefiting blind or handicapped persons. Established by Anthony F. Bauer, it aims to provide lasting support for those in need. To be eligible, organizations must be 501(c)(3) exempt and primarily operate in Connecticut. The fund does not support general operating costs, endowments, individuals, or political activities. This initiative reflects Mr. Bauer's legacy of generosity and commitment to aiding vulnerable communities.

The Pauline Miguel Scholarship, established by the daughters of Pauline Miguel, honors her dedication to the educational success of Tohono O’Odham Nation members. This scholarship awards a $1,000 grant annually to a graduating senior from specific high schools in Southern Arizona, provided they maintain a GPA of 2.5 or higher. This initiative reflects the Community Foundation for Southern Arizona's commitment to fostering future leaders in the community through educational support.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Health Equity Fund

Help with healthcare costs for mucopolysaccharidosis type VII (health equity)

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The Mary Katherine "Katy" Williamson Scholarship Fund honors the memory of Katy Williamson, established by her family after her passing in 2005. This scholarship supports students pursuing degrees in healthcare, both human and animal, at accredited institutions in the U.S. Recipients may renew the award annually for up to four years, contingent on maintaining eligibility. The fund reflects Katy's love for animals and nature, aiming to empower future generations to contribute positively to society.

The Mike Condon Memorial Scholarship offers financial support to students interested in construction, with awards of up to $1,500 per year. Applicants must have a minimum 2.25 GPA and reside in Clinton, Scott, or Muscatine counties. The scholarship allows for reapplication up to four times, emphasizing trade experience. Preference is given to those with relevant educational backgrounds or participation in construction-related activities, ensuring a focus on developing skills in this vital industry.

The Loren and Tammy Bockwoldt Family Scholarship, administered by the Quad Cities Community Foundation, awards up to $2,000 annually to three qualified students, totaling no more than $6,000. Applicants must be high school seniors from Durant or Wilton, Iowa, with a minimum GPA of 2.5 and demonstrated financial need. The scholarship is renewable for up to four years, supporting students aiming for full-time enrollment in accredited post-secondary institutions.

The Kellly Marie Mcquate Memorial Scholarship, offered by the Quad Cities Community Foundation, supports graduating high school seniors from Rock Island or Scott County, IL, who have lost a parent. This need-based scholarship awards up to $500 and focuses on financial need as the primary criterion. Applicants must plan to enroll full-time in college, with merit evaluated through school and community activities. This scholarship represents a significant opportunity for eligible students to pursue their educational goals.

The George S. Souten Performing Arts Scholarship, offered by the Four County Community Foundation, supports high school seniors from Armada, Capac, Imlay City, and Romeo who plan to major or minor in performing arts. Applicants must demonstrate a strong background in the arts and submit an essay. Awardees will be recognized during the Foundation's Scholarship Celebration in May and at their respective high school awards events.

American Gastroenterological Association

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization.

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

This award provides funding for three years to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in inflammatory bowel disease (IBD) research.

Objective

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). This award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research pertaining to inflammatory bowel disease.

Review all of the benefits AGA Research Scholar Award recipients are entitled to on the award policies page.

Application Requirements

• Maintain AGA membership throughout the three-year duration of the award.

• Applicants must self-assign their proposal to one of the following categories:
  • Clinical: Research involving direct contact with human subjects or using clinical data to address problems related to the prevention, diagnosis, treatment or outcome of human diseases (e.g., clinical epidemiology). This category also includes research related to health care delivery (e.g., health services, health IT).
  • Basic/Translational: Research with a primary goal of understanding basic biology or disease mechanisms. This category can involve animal subjects, cell culture, human biospecimens or human data as resources for laboratory- or informatics-based investigation.

• Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 50 percent effort to the proposed project.

• Applicants are required to have a sponsor and mentor for the award; one individual may serve in the capacity of both positions. A sponsor (typically a division chief or department chair) is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables and will work with the applicant to create a research career development plan.

• The intent of this award is to foster the scientific independence of junior investigators. Applicants whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It must also be clearly stated how the work submitted by the applicant is that of the applicant and not that of the senior mentor(s).

• A complete research facilities and resources form must be submitted.

• Biographical sketches for the applicant, mentor and other key personnel must be submitted.

• Applicants resubmitting a revised application from a prior cycle must include a resubmission report describing responses to reviewer feedback and other major changes since the most recent past submission.

• Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee(s) for use of human subjects or animals. If approval is not necessary, then the recipient must provide documentation from the appropriate regulatory committee.

• Recipients must submit scientific and financial progress reports to AGA annually and final reports 60 days after the end date of the award period. Report templates and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.

• All publications, presentations, abstracts, and patent applications arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.

• Additional pre-award policies are available on the Research Award Policies page.

Award Overlap

• At the time of application submission, applicants may not hold, or have held, an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (e.g., the American Liver Foundation, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation).

• Applicants who have held a K12 or KL2 in the past are eligible to apply. Applicants with an active K12 or KL2 may apply in the final year of their active K12 or KL2 so long as the award will end before the Research Scholar Award term begins.

• If a applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, then the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

• If the recipient is notified that a comparable award has been granted after the first payment of this award, then the recipient may retain up to 50 percent of the remainder of his or her AGA award. AGA must be notified by the recipient via email within two weeks of receiving notification of additional funding.

The Pichichero Family Foundation Research Development Award supports innovative research in pediatric infectious diseases, focusing on vaccine development and pathogenesis. Established in 2016, it encourages both new and established investigators to apply for grants of one to two years. Eligible applicants must be members of the Pediatric Infectious Diseases Society (PIDS) and should aim to create novel insights into vaccine and therapeutic advancements, avoiding overlap with existing funding sources.

The John R. Kiley Memorial Scholarship, offered by the Quad Cities Community Foundation, provides need-based financial assistance of up to $1,500 for students pursuing a Bachelor's Degree. Applicants must have a GPA of at least 3.25 and be enrolled or planning to enroll in college. Iowa residents can attend any institution, while Illinois residents may attend colleges in Iowa only. This scholarship emphasizes financial need, leadership, and academic merit.